# Stoke Therapeutics, Inc.: Form SC 13D/A, filed Sep 23, 2024

- Company: [Stoke Therapeutics, Inc.](/companies/stok.md) (CIK 1623526)
- Form: SC 13D/A
- Filed: 2024-09-23
- Accepted by EDGAR: Sep 23, 2024, 16:22 ET
- Period: not reported
- Accession: 0001123292-24-000282
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1623526/000112329224000282/stoke13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1623526/000112329224000282/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1623526/000112329224000282/stoke13d.htm

Filed Sep 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001123292-24-000282. Last ingested by Listed: Nov 14, 2026, 21:52 ET. No prices; not investment advice.
